186 related articles for article (PubMed ID: 37719847)
1. Exploration of 2D and 3D-QSAR analysis and docking studies for novel dihydropteridone derivatives as promising therapeutic agents targeting glioblastoma.
Pan M; Cheng L; Wang Y; Lyu C; Hou C; Zhang Q
Front Pharmacol; 2023; 14():1249041. PubMed ID: 37719847
[No Abstract] [Full Text] [Related]
2. 3D,2D-QSAR study and docking of novel quinazolines as potential target drugs for osteosarcoma.
Lian Z; Sang C; Li N; Zhai H; Bai W
Front Pharmacol; 2023; 14():1124895. PubMed ID: 36895941
[No Abstract] [Full Text] [Related]
3. 3D- and 2D-QSAR models' study and molecular docking of novel nitrogen-mustard compounds for osteosarcoma.
Zhuo W; Lian Z; Bai W; Chen Y; Xia H
Front Mol Biosci; 2023; 10():1164349. PubMed ID: 37065446
[No Abstract] [Full Text] [Related]
4. 2D, 3D-QSAR study and docking of vascular endothelial growth factor receptor 3 (VEGFR3) inhibitors for potential treatment of retinoblastoma.
Ren R; Gao L; Li G; Wang S; Zhao Y; Wang H; Liu J
Front Pharmacol; 2023; 14():1177282. PubMed ID: 37089961
[No Abstract] [Full Text] [Related]
5. Computational modelling studies of some 1,3-thiazine derivatives as anti-influenza inhibitors targeting H1N1 neuraminidase via 2D-QSAR, 3D-QSAR, molecular docking, and ADMET predictions.
Abdullahi M; Uzairu A; Shallangwa GA; Mamza PA; Ibrahim MT
Beni Suef Univ J Basic Appl Sci; 2022; 11(1):104. PubMed ID: 36000144
[TBL] [Abstract][Full Text] [Related]
6. Improved 3D-QSAR Prediction by Multiple Conformational Alignments and Molecular Docking Studies to Design and Discover HIV-I Protease Inhibitors.
Patel PK; Bhatt HG
Curr HIV Res; 2021; 19(2):154-171. PubMed ID: 33213349
[TBL] [Abstract][Full Text] [Related]
7. Exploration of 3,6-dihydroimidazo(4,5-d)pyrrolo(2,3-b)pyridin-2(1H)-one derivatives as JAK inhibitors using various in silico techniques.
Jisha RS; Aswathy L; Masand VH; Gajbhiye JM; Shibi IG
In Silico Pharmacol; 2017; 5():9. PubMed ID: 29085766
[TBL] [Abstract][Full Text] [Related]
8. Combined pharmacophore modeling, docking, and 3D-QSAR studies of PLK1 inhibitors.
Lu S; Liu HC; Chen YD; Yuan HL; Sun SL; Gao YP; Yang P; Zhang L; Lu T
Int J Mol Sci; 2011; 12(12):8713-39. PubMed ID: 22272100
[TBL] [Abstract][Full Text] [Related]
9. QSAR Study of Novel 1, 8-Naphthimide Derivatives Targeting Nuclear DNA.
Lian Z; Tai Y; Xia H; Zhai H
Anticancer Agents Med Chem; 2023; 23(6):726-733. PubMed ID: 36017845
[TBL] [Abstract][Full Text] [Related]
10. Molecular Modeling Studies of Anti-Alzheimer Agents by QSAR, Molecular Docking and Molecular Dynamics Simulations Techniques.
Abdizadeh R; Hadizadeh F; Abdizadeh T
Med Chem; 2020; 16(7):903-927. PubMed ID: 31385775
[TBL] [Abstract][Full Text] [Related]
11. In-silico modelling studies of 5-benzyl-4-thiazolinone derivatives as influenza neuraminidase inhibitors via 2D-QSAR, 3D-QSAR, molecular docking, and ADMET predictions.
Abdullahi M; Uzairu A; Shallangwa GA; Mamza PA; Ibrahim MT
Heliyon; 2022 Aug; 8(8):e10101. PubMed ID: 36016519
[TBL] [Abstract][Full Text] [Related]
12. Design of Novel Chemotherapeutic Agents Targeting Checkpoint Kinase 1 Using 3D-QSAR Modeling and Molecular Docking Methods.
Balupuri A; Balasubramanian PK; Cho SJ
Curr Comput Aided Drug Des; 2016; 12(4):302-313. PubMed ID: 27585602
[TBL] [Abstract][Full Text] [Related]
13.
Shirvani P; Fassihi A
J Biomol Struct Dyn; 2022 Aug; 40(13):5965-5982. PubMed ID: 33475043
[TBL] [Abstract][Full Text] [Related]
14. New Research for Quinazoline-2,4-diones as HPPD Inhibitors Based on 2D-MLR and 3D-QSAR Models.
Fu Y; Sun YN; Cao HF; Yi KH; Zhao LX; Li JZ; Ye F
Comb Chem High Throughput Screen; 2017; 20(9):748-759. PubMed ID: 28637410
[TBL] [Abstract][Full Text] [Related]
15. 3D-QSAR and molecular docking studies on derivatives of MK-0457, GSK1070916 and SNS-314 as inhibitors against Aurora B kinase.
Zhang B; Li Y; Zhang H; Ai C
Int J Mol Sci; 2010 Nov; 11(11):4326-47. PubMed ID: 21151441
[TBL] [Abstract][Full Text] [Related]
16. A Combined Approach of Pharmacophore Modeling, QSAR Study, Molecular Docking and In silico ADME/Tox Prediction of 4-Arylthio & 4-Aryloxy-3- Iodopyridine-2(1H)-one Analogs to Identify Potential Reverse Transcriptase Inhibitor: Anti-HIV Agents.
Panigrahi D; Mishra A; Sahu SK; Azam MA; Vyshaag CM
Med Chem; 2022; 18(1):51-87. PubMed ID: 33319692
[TBL] [Abstract][Full Text] [Related]
17. Combined 3D-QSAR modeling and molecular docking study on indolinone derivatives as inhibitors of 3-phosphoinositide-dependent protein kinase-1.
AbdulHameed MD; Hamza A; Liu J; Zhan CG
J Chem Inf Model; 2008 Sep; 48(9):1760-72. PubMed ID: 18717540
[TBL] [Abstract][Full Text] [Related]
18. Molecular Docking, G-QSAR Studies, Synthesis and Anticancer Screening of Some New 2-Phenazinamines as Bcr-Abl Tyrosine Kinase Inhibitors.
Kale MA; Sonwane GM
Curr Drug Discov Technol; 2020; 17(2):213-224. PubMed ID: 30210004
[TBL] [Abstract][Full Text] [Related]
19. Design of novel amyloid β aggregation inhibitors using QSAR, pharmacophore modeling, molecular docking and ADME prediction.
Aswathy L; Jisha RS; Masand VH; Gajbhiye JM; Shibi IG
In Silico Pharmacol; 2018; 6(1):12. PubMed ID: 30607325
[TBL] [Abstract][Full Text] [Related]
20. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
